Literature DB >> 12727196

Properties of purified recombinant human polyamine oxidase, PAOh1/SMO.

Yanlin Wang1, Tracy Murray-Stewart, Wendy Devereux, Amy Hacker, Benjamin Frydman, Patrick M Woster, Robert A Casero.   

Abstract

The discovery of an inducible oxidase whose apparent substrate preference is spermine indicates that polyamine catabolism is more complex than that originally proposed. To facilitate the study of this enzyme, the purification and characterization of the recombinant human PAOh1/SMO polyamine oxidase are reported. Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine. The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1/SMO. The results of these studies are consistent with the hypothesis that PAOh1/SMO represents a new addition to the polyamine metabolic pathway that may represent a new target for antineoplastic drug development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727196     DOI: 10.1016/s0006-291x(03)00636-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  51 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

2.  Overproduction of cardiac S-adenosylmethionine decarboxylase in transgenic mice.

Authors:  Oleg Nisenberg; Anthony E Pegg; Patricia A Welsh; Kerry Keefer; Lisa M Shantz
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.

Authors:  Candace S Hayes; Karen DeFeo-Mattox; Patrick M Woster; Susan K Gilmour
Journal:  Amino Acids       Date:  2013-07-25       Impact factor: 3.520

4.  A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.

Authors:  Candace S Hayes; Karen Defeo; Hong Dang; Carol S Trempus; Rebecca J Morris; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2011-07-05       Impact factor: 4.944

5.  Reduction in polyamine catabolism leads to spermine-mediated airway epithelial injury and induces asthma features.

Authors:  V Jain; S Raina; A P Gheware; R Singh; R Rehman; V Negi; T Murray Stewart; U Mabalirajan; A K Mishra; R A Casero; A Agrawal; B Ghosh
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

6.  Mechanistic studies of human spermine oxidase: kinetic mechanism and pH effects.

Authors:  Mariya S Adachi; Paul R Juarez; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

7.  Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases.

Authors:  Merja R Häkkinen; Mervi T Hyvönen; Seppo Auriola; Robert A Casero; Jouko Vepsäläinen; Alex R Khomutov; Leena Alhonen; Tuomo A Keinänen
Journal:  Amino Acids       Date:  2009-12-10       Impact factor: 3.520

8.  Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.

Authors:  Gang Wei; Karen DeFeo; Candace S Hayes; Patrick M Woster; Laura Mandik-Nayak; Susan K Gilmour
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

9.  Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.

Authors:  Yi Huang; Tracy Murray Stewart; Yu Wu; Stephen B Baylin; Laurence J Marton; Brandy Perkins; Richard J Jones; Patrick M Woster; Robert A Casero
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

10.  Pentamines as substrate for human spermine oxidase.

Authors:  Koichi Takao; Akira Shirahata; Keijiro Samejima; Robert Anthony Casero; Kazuei Igarashi; Yoshiaki Sugita
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.